«

»

Outpace Bio Raises $30 Million To Design Next Generation Cell Therapies

The Seattle-based startup draws on principles of protein design and cellular control to improve targeted cell therapies

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive